Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease: Report of two cases

10Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Melanoma differentiation-associated protein 5 (MDA5) antibody-positive dermatomyositis (DM) displays unique cutaneous and pathologic features. We describe two cases of myositis-associated rapidly progressive interstitial lung disease (RP-ILD). The patients were two women from Kerala, India. Both patients had anti-MDA5 antibody-positive myositis. Both patients presented with RP-ILD without any clinical features of myositis and succumbed to their illness despite aggressive medical treatment. Anti-MDA5-antibody-positive DM is characterised by amyopathic disease with rapidly progressive and fatal ILD.

Cite

CITATION STYLE

APA

Mehta, A. A., Paul, T., Cb, M., & Haridas, N. (2021). Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease: Report of two cases. BMJ Case Reports, 14(4). https://doi.org/10.1136/bcr-2020-240046

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free